Current Medicinal Chemistry

Author(s): Christoph Gerhardt

DOI: 10.2174/092986732617190820123648

DownloadDownload PDF Flyer Cite As
Treatment of Ciliopathies: Current Perspectives

Page: [3080 - 3080] Pages: 1

  • * (Excluding Mailing and Handling)

[1]
Stayner, C.; Brooke, D.; Bates, M.; Eccles, M. Targeted therapies for autosomal dominant polycystic kidney disease. Curr. Med. Chem., 2019, 26(17), 3081-3102.
[2]
Uytingco, C.; Green, W.; Martens, J. Olfactory loss and dysfunction in ciliopathies: Molecular mechanisms and potential therapies. Curr. Med. Chem., 2019, 26(17), 3103-3119.
[3]
Shivanna, M.; Anand, M.; Chakrabarti, S.; Khanna, H. Ocular ciliopathies: genetic and mechanistic insights into developing therapies. Curr. Med. Chem., 2019, 26(17), 3120-3131.